Total microbial quality control management in blood banks:
Blood and cellular therapy products are a pharmaceutical product by law in most countries worldwide. Therefore, production, quality control and inspection guidelines for blood establishments are based on / derived from guidelines originally developed for pharmaceuticals. The risk for bacterial transfusion transmitted infections in blood and cell therapy products is more and more acknowledged in the latest years. Root-cause analysis to investigate the contamination origin of these products and to take, if applicable, corrective preventive actions will have increasing attention in the blood and cell therapy production industry in the next couple of years.
bioMerieux, a pioneer in bacterial detection in the blood collection industry with the BacT/ALERT® 3D system, proposes complete solutions for environmental monitoring and microbial identification.
Click here for cord blood, stem cells and tissue testing.